PPARγ-overexpressing/silenced colorectal cancer (CRC) cells are studied by proteomics.
The differentially expressed proteins are part of novel PPARγ signaling pathways.
Ezrin, LaminA/C, α-enolase, prohibitin and RuvBlike2 strongly correlate with PPARγ.
These proteins correlate with tumor expression in publicly available CRC dataset.